Skip to main content
. 2019 Oct 14;6(12):e616–e629. doi: 10.1016/S2352-3026(19)30167-X

Figure 1.

Figure 1

Trial profile of Myeloma XI

Area highlighted is the CVD randomisation reported in this manuscript. C=cyclophosphamide. D=dexamethasone. R=lenalidomide. T=thalidomide. V=bortezomib.